# Fresh Intravenous Blood Samples for TBI Diagnostic Assay Development With Philips Point of Care System

> **NCT03060109** · — · TERMINATED · sponsor: **Banyan Biomarkers, Inc** · enrollment: 317 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **OTHER:** Blood draw within 12 hours of injury

## Key facts

- **NCT ID:** NCT03060109
- **Lead sponsor:** Banyan Biomarkers, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06-21
- **Primary completion:** 2017-09-10
- **Final completion:** 2017-09-10
- **Target enrollment:** 317 (ACTUAL)
- **Why stopped:** Diagnostic platform no longer under development; study termination not related to any safety issues
- **Last updated:** 2017-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03060109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03060109, "Fresh Intravenous Blood Samples for TBI Diagnostic Assay Development With Philips Point of Care System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03060109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*